🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Steven D. Gore

University of New Haven

ORCID: 0000-0002-2349-2701

Also affiliated with National Cancer Institute, National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “NCI 9938: Phase I clinical trial of ATR inhibitor berzosertib (M6620, VX-970) in combination with irinotecan in patients with advanced solid tumors.”.

NCI 9938: Phase I clinical trial of ATR inhibitor berzosertib (M6620, VX-970) in combination with irinotecan in patients with advanced solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3012

N/A

0.396DataRank · unranked

13 citations

Karen Kelly, Saiama N. Waqar, Elizabeth J. Davis, Geoffrey I. Shapiro, Patricia LoRusso +7 more

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax

Biomedical Chromatography(2021)10.1002/bmc.5289

N/A

0DataRank · unranked

4 citations

Nicole M. Anders, Ping He, Avelina Hemingway, Steven D. Gore, Christine L. Hann +2 more

A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3174

N/A

0DataRank · unranked

5 citations

Paul Frankel, Jan H. Beumer, Naoko Takebe, Ming Yin, Hamid Emamekhoo +4 more